Sector Update: Healthcares

By
A A A

Healthcare shares were generally lower in pre-market trade on Friday.

In healthcare stocks news, Kamada ( KMDA ) is lower after the company announced preliminary top-line results from the Phase II/III pivotal clinical trial in Europe and Canada of its proprietary inhaled Alpha-1 Antitrypsin ( AAT ) therapy to treat Alpha-1 Antitrypsin Deficiency (AATD or inherited emphysema).

And, Abbott ( ABT ) edged lower in recent pre-market trading on Friday after saying it has signed a definitive agreement to buy Latin American pharmaceutical company CFR Pharmaceuticals for approximately $2.9 billion, plus the assumption of debt of approximately $430 million.

ABT closed down to $39.24 Thursday, in a 52-week range of $32.70 - $40.49.

And, Bovie Medical ( BVX ) said late Thursday that Q1 sales were $6.5 million, up 14% from a year ago. Adjusted net loss was $0.01 per share, down from a loss of $0.02 last year.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: KMDA , AAT , ABT , BVX

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

45,338,036
  • $42.685 ▲ 1.43%
32,946,120
  • $5.1599 ▼ 4.62%
28,536,235
  • $17.01 ▼ 0.18%
27,050,553
  • $46.87 ▲ 0.41%
23,096,435
  • $101.36 ▼ 0.42%
20,279,389
  • $39.585 ▼ 4.73%
17,681,960
  • $34.97 ▼ 0.57%
14,988,933
  • $25.2134 ▼ 0.03%
As of 9/19/2014, 10:33 AM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com